1,019
Views
33
CrossRef citations to date
0
Altmetric
Review Articles

The aging brain: impact of heavy metal neurotoxicity

ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon
Pages 801-814 | Received 14 Jul 2020, Accepted 14 Oct 2020, Published online: 19 Nov 2020

References

  • Adlaf EW, Vaden RJ, Niver AJ, Manuel AF, Onyilo VC, Araujo MT, Dieni CV, Vo HT, King GD, Wadiche JI, et al. 2017. Adult-born neurons modify excitatory synaptic transmission to existing neurons. Elife. 6:e19886.
  • Adlard PA, Parncutt JM, Finkelstein DI, Bush AI. 2010. Cognitive loss in zinc transporter-3 knock-out mice: a phenocopy for the synaptic and memory deficits of Alzheimer's disease? J Neurosci. 30(5):1631–1636.
  • Albinet CT, Boucard G, Bouquet CA, Audiffren M. 2012. Processing speed and executive functions in cognitive aging: How to disentangle their mutual relationship? Brain Cogn. 79(1):1–11.
  • Altenhofen S, Wiprich MT, Nery LR, Leite CE, Vianna MRMR, Bonan CD. 2017. Manganese(II) chloride alters behavioral and neurochemical parameters in larvae and adult zebrafish. Aquat Toxicol. 182:172–183.
  • Ando H, Kawaai K, Bonneau B, Mikoshiba K. 2018. Remodeling of Ca2+ signaling in cancer: Regulation of inositol 1,4,5-trisphosphate receptors through oncogenes and tumor suppressors . Adv Biol Regul. 68:64–76.
  • Appleton JP, Scutt P, Sprigg N, Bath PM. 2017. Hypercholesterolaemia and vascular dementia. Clin Sci (Lond). 131(14):1561–1578.
  • Arosio P, Elia L, Poli M. 2017. Ferritin, cellular iron storage and regulation. IUBMB Life. 69(6):414–422.
  • Aschner M. 2000. Manganese: brain transport and emerging research needs. Environ Health Perspect. 108(suppl 3):429–432.
  • Ashraf GM, Greig NH, Khan TA, Hassan I, Tabrez S, Shakil S, Sheikh IA, Zaidi SK, Akram M, Jabir NR. 2014. Protein misfolding and aggregation in Alzheimer’s disease and type 2 diabetes mellitus. CNS Neurol Disorders Drug Targets. 13(7):1280–1293.
  • Ashraf A, Clark M, So P-W. 2018. The aging of iron man. Front Aging Neurosci. 10:65
  • Ashraf A, Michaelides C, Walker TA, Ekonomou A, Suessmilch M, Sriskanthanathan A, Abraha S, Parkes A, Parkes HG, Geraki K, et al. 2019. Regional distributions of iron, copper and zinc and their relationships with glia in a normal aging mouse model. Front Aging Neurosci. 11:351.
  • Balaban RS, Nemoto S, Finkel T. 2005. Mitochondria, oxidants, and aging. cell. 120(4):483–495.
  • Bayot A, Santos R, Camadro J-M, PJBm R. 2011. Friedreich's ataxia: the vicious circle hypothesis revisited. BMC Med. 9(1):112.
  • Beckervordersandforth R, Ebert B, Schäffner I, Moss J, Fiebig C, Shin J, Moore DL, Ghosh L, Trinchero MF, Stockburger C, et al. 2017. Role of mitochondrial metabolism in the control of early lineage progression and aging phenotypes in adult hippocampal neurogenesis. Neuron. 93(3):560–573.
  • Benzi G, Moretti A. 2018. Glutathione in brain aging and neurodegenerative disorders. In: Shaw CS, editor. Glutathione in the nervous system. Boca Raton: Routledge; p. 231–256.
  • Berridge MJ. JPr. 2016. The inositol trisphosphate/calcium signaling pathway in health and disease. Physiol Rev. 96(4):1261–1296.
  • Boland B, Yu WH, Corti O, Mollereau B, Henriques A, Bezard E, Pastores GM, Rubinsztein DC, Nixon RA, Duchen MR, et al. 2018. Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing. Nat Rev Drug Discov. 17(9):660–688.
  • Braidy N, Poljak A, Grant R, Jayasena T, Mansour H, Chan-Ling T, Guillemin GJ, Smythe G, Sachdev P. 2014. Mapping NAD(+) metabolism in the brain of ageing Wistar rats: potential targets for influencing brain senescence. Biogerontology. 15(2):177–198.
  • Braidy N, Poljak A, Marjo C, Rutlidge H, Rich A, Jugder B-E, Jayasena T, Inestrosa NC, Sachdev PS. 2017. Identification of cerebral metal ion imbalance in the brain of aging Octodon degus. Front Aging Neurosci. 9:66.
  • Bulcke F, Dringen R, Scheiber IF. 2017. Neurotoxicity of copper. In: Aschner M, Costa LG, editors. Neurotoxicity of Metals. Cham: Springer; p. 313–343.
  • Burdo JR, Connor JR. 2003. Brain iron uptake and homeostatic mechanisms: an overview. Biometals. 16(1):63–75.
  • Burikhanov R, Zhao Y, Goswami A, Qiu S, Schwarze SR, Rangnekar VM. 2009. The tumor suppressor Par-4 activates an extrinsic pathway for apoptosis. Cell. 138(2):377–388.
  • Caito S, Aschner M. 2015. Neurotoxicity of metals, Chapter 11. In: Lotti M, Bleecker ML, editors. Occupational Neurology. Amsterdam: Elsevier; p. 169–189.
  • Castelli V, Benedetti E, Antonosante A, Catanesi M, Pitari G, Ippoliti R, Cimini A, d'Angelo M. Fimn. 2019. Neuronal cells rearrangement during aging and neurodegenerative disease: metabolism, oxidative stress and organelles dynamic. Front Mol Neurosci. 12:132.
  • Chang L-C, Chiang S-K, Chen S-E, Yu Y-L, Chou R-H, Chang W-C. 2018. Heme oxygenase-1 mediates BAY 11-7085 induced ferroptosis. Cancer Lett. 416:124–137.
  • Chaudhry P, Singh M, Parent S, Asselin E. 2012. Prostate apoptosis response 4 (Par-4), a novel substrate of caspase-3 during apoptosis activation. Mol Cell Biol. 32(4):826–839.
  • Cheung EC, Melanson-Drapeau L, Cregan SP, Vanderluit JL, Ferguson KL, McIntosh WC, Park DS, Bennett SA, Slack RS. 2005. Apoptosis-inducing factor is a key factor in neuronal cell death propagated by BAX-dependent and BAX-independent mechanisms. J Neurosci. 25(6):1324–1334.
  • Chi H, Chang H-Y, Sang T-K. 2018. Neuronal cell death mechanisms in major neurodegenerative diseases. IJMS. 19(10):3082.
  • Corella D, Ramírez-Sabio JB, Coltell O, Ortega-Azorín C, Estruch R, Martínez-González MA, Salas-Salvadó J, Sorlí JV, Castañer O, Arós F, et al. 2018. Effects of the Ser326Cys polymorphism in the DNA repair OGG1 gene on cancer, cardiovascular, and all-cause mortality in the PREDIMED Study: Modulation by diet. J Acad Nutr Dietetics. 118(4):589–605.
  • Correia AR, Wang T, Craig EA, Gomes C. 2010. Iron-binding activity in yeast frataxin entails a trade off with stability in the alpha1/beta1 acidic ridge region . Biochem J. 426(2):197–203.
  • Costa LG, Pellacani C, Guizzetti M. 2017. In vitro and alternative approaches to developmental neurotoxicity, Chapter 14. Gupta RC, editor. In: Reproductive and developmental toxicology. London: Academic Press; p. 241–253.
  • Crichton RR, Dexter DT, Ward RJ. 2011. Brain iron metabolism and its perturbation in neurological diseases. Journal of Neural Transmission. 118(3):301–314.
  • da Silva PF, Schumacher B. 2019. DNA damage responses in ageing. Open Biol. 9(11):190168.
  • Davies KM, Hare DJ, Cottam V, Chen N, Hilgers L, Halliday G, Mercer JF, Double KL. 2013. Localization of copper and copper transporters in the human brain. Metallomics. 5(1):43–51.
  • Denis I, Potier B, Vancassel S, Heberden C, Lavialle M. 2013. Omega-3 fatty acids and brain resistance to ageing and stress: body of evidence and possible mechanisms. Ageing Res Rev. 12(2):579–594.
  • Deshpande A, Kawai H, Metherate R, Glabe CG, Busciglio J. 2009. A role for synaptic zinc in activity-dependent Abeta oligomer formation and accumulation at excitatory synapses. J Neurosci. 29(13):4004–4015.
  • Dodd CA, Filipov NM. 2011. Manganese potentiates LPS-induced heme-oxygenase 1 in microglia but not dopaminergic cells: role in controlling microglial hydrogen peroxide and inflammatory cytokine output. Neurotoxicology. 32(6):683–692.
  • Emsley JG, Mitchell BD, Kempermann G, Macklis JD. 2005. Adult neurogenesis and repair of the adult CNS with neural progenitors, precursors, and stem cells. Prog Neurobiol. 75(5):321–341.
  • Eskici G, Axelsen PH. 2012. Copper and oxidative stress in the pathogenesis of Alzheimer's disease. Biochemistry. 51(32):6289–6311.
  • Fan J, Dawson TM, Dawson VL, et al. 2017. Cell death mechanisms of neurodegeneration. In: Beart P, Robinson M, Rattray M., editors. Neurodegenerative Diseases. Cham: Springer; p. 403–425.
  • Fang EF, Scheibye-Knudsen M, Chua KF, Mattson MP, Croteau DL, Bohr VA. 2016. Nuclear DNA damage signalling to mitochondria in ageing. Nat Rev Mol Cell Biol. 17(5):308–321.
  • Farina M, Avila DS, Da Rocha JBT, Aschner M. 2013. Metals, oxidative stress and neurodegeneration: a focus on iron, manganese and mercury. Neurochem Int. 62(5):575–594.
  • Fernsebner K, Zorn J, Kanawati B, Walker A, Michalke B. 2014. Manganese leads to an increase in markers of oxidative stress as well as to a shift in the ratio of Fe(II)/(III) in rat brain tissue. Metallomics. 6(4):921–931.
  • Filipov NM, Dodd CA. 2012. Role of glial cells in manganese neurotoxicity. J Appl Toxicol. 32(5):310–317.
  • Filipov NM, Seegal RF, Lawrence DA. 2005. Manganese potentiates in vitro production of proinflammatory cytokines and nitric oxide by microglia through a nuclear factor kappa B-dependent mechanism. Toxicol Sci. 84(1):139–148.
  • Gant JC, Kadish I, Chen K-C, Thibault O, Blalock EM, Porter NM, Landfield P. 2018. Aging-related calcium dysregulation in rat entorhinal neurons homologous with the human entorhinal neurons in which Alzheimer's Disease Neurofibrillary Tangles First Appear. J Alzheimers Dis. 66(4):1371–1378.
  • Gant JC, Sama MM, Landfield PW, Thibault O. 2006. Early and simultaneous emergence of multiple hippocampal biomarkers of aging is mediated by Ca2+-induced Ca2+ release. J Neurosci. 26(13):3482–3490.
  • Garrick MD, Dolan KG, Horbinski C, Ghio AJ, Higgins D, Porubcin M, Moore EG, Hainsworth LN, Umbreit JN, Conrad ME, et al. 2003. DMT1: a mammalian transporter for multiple metals. Biometals. 16(1):41–54.
  • Geula C, Bu J, Nagykery N, Scinto LF, Chan J, Joseph J, Parker R, Wu CK. 2003. Loss of calbindin-D28k from aging human cholinergic basal forebrain: relation to neuronal loss . J Comp Neurol. 455(2):249–259.
  • Giese A, Buchholz M, Herms J, Kretzschmar HA. 2005. Mouse brain synaptosomes accumulate copper-67 efficiently by two distinct processes independent of cellular prion protein. J Mol Neurosci. 27(3):347–354.
  • Goedert M. 2005. Tau gene mutations and their effects. Mov Disord. 20(S12):S45–S52.
  • Gunter TE, Gavin CE, Aschner M, Gunter KK. 2006. Speciation of manganese in cells and mitochondria: a search for the proximal cause of manganese neurotoxicity. Neurotoxicology. 27(5):765–776.
  • Hahn P, Song Y, Ying G-s, He X, Beard J, Dunaief JL. 2009. Age-dependent and gender-specific changes in mouse tissue iron by strain. Exp Gerontol. 44(9):594–600.
  • Hancock SM, Finkelstein DI, Adlard PA. 2014. Glia and zinc in ageing and Alzheimer's disease: a mechanism for cognitive decline? Front Aging Neurosci. 6:137
  • Hare DJ, Cardoso BR, Raven EP, Double KL, Finkelstein DI, Szymlek-Gay EA, Biggs B-AJnPsD. 2017. Excessive early-life dietary exposure: a potential source of elevated brain iron and a risk factor for parkinson’s disease. npj Parkinson's Disease. 3(1):1–5.
  • Hebbar N, Burikhanov R, Shukla N, Qiu S, Zhao Y, Elenitoba-Johnson KSJ, Rangnekar VM. 2017. A naturally generated decoy of the prostate apoptosis response-4 protein overcomes therapy resistance in tumors. Cancer Res. 77(15):4039–4050.
  • Higashi Y, Segawa S, Matsuo T, Nakamura S, Kikkawa Y, Nishida K, Nagasawa K. 2011. Microglial zinc uptake via zinc transporters induces ATP release and the activation of microglia. Glia. 59(12):1933–1945.
  • Hofer SM, Berg S, Era P. 2003. Evaluating the interdependence of aging-related changes in visual and auditory acuity, balance, and cognitive functioning. Psychol Aging. 18(2):285–305.
  • Hou Y, Lautrup S, Cordonnier S, Wang Y, Croteau DL, Zavala E, Zhang Y, Moritoh K, O'Connell JF, Baptiste BA, et al. 2018. NAD + supplementation normalizes key Alzheimer's features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency. Proc Natl Acad Sci USA. 115(8):E1876–E1885.
  • Ijomone OM, Ijomone OK, Iroegbu JD, Ifenatuoha CW, Olung NF, Aschner M. 2020. Epigenetic influence of environmentally neurotoxic metals. NeuroToxicology. 81:51–65.
  • Ijomone OM, Miah MR, Akingbade GT, Bucinca H, Aschner M. 2020. Nickel-Induced Developmental Neurotoxicity in C. elegans Includes Cholinergic, Dopaminergic and GABAergic Degeneration, Altered behaviour, and increased skn-1 activity. Neurotoxicity Res. 37:1–11.
  • Ijomone OM, Okori SO, Ijomone OK, Ebokaiwe AP. 2018. Sub-acute nickel exposure impairs behavior, alters neuronal microarchitecture, and induces oxidative stress in rats' brain. Drug Chem Toxicol. 41(4):377–384.
  • Isaev NK, Stelmashook EV, Genrikhs EE. 2019. Neurogenesis and brain aging. Rev Neurosci. 30(6):573–580.
  • Karch J, Bround MJ, Khalil H, Sargent MA, Latchman N, Terada N, Peixoto PM, Molkentin JD. 2019. Inhibition of mitochondrial permeability transition by deletion of the ANT family and CypD. Sci Adv. 5(8):eaaw4597.
  • Keller JN, Gee J, Ding Q. 2002. The proteasome in brain aging. Ageing Res Rev. 1(2):279–293.
  • Kempermann G. 2015. Activity dependency and aging in the regulation of adult neurogenesis. Cold Spring Harb Perspect Biol. 7(11):a018929.
  • Klevay LM. 2008. Alzheimer's disease as copper deficiency. Med Hypotheses. 70(4):802–807.
  • Knoch ME, Hartnett KA, Hara H, Kandler K, Aizenman E. 2008. Microglia induce neurotoxicity via intraneuronal Zn(2+) release and a K(+) current surge. Glia. 56(1):89–96.
  • Kojer K, Hering T, Bazenet C, Weiss A, Herrmann F, Taanman J-W, Orth M. 2019. Huntingtin aggregates and mitochondrial pathology in skeletal muscle but not heart of late-stage R6/2 mice. J Huntingtons Dis. 8(2):145–159.
  • Kuttan R, Binitha P. 2017. Neuroprotective activity of curcumin and emblica officinalis extract against carbofuran-induced neurotoxicity in wistar rats, Chapter 23. In: Farooqui T, Farooqui AA, editors. Neuroprotective Effects of Phytochemicals in Neurological Disorders. New Jersey: John Wiley & Sons, Inc; p. 447–461.
  • Lazarov O, Mattson MP, Peterson DA, Pimplikar SW, van Praag H. 2010. When neurogenesis encounters aging and disease. Trends Neurosci. 33(12):569–579.
  • Lech T, Sadlik J. 2007. Copper concentration in body tissues and fluids in normal subjects of southern Poland. Biol Trace Elem Res. 118(1):10–15.
  • L'Episcopo F, Tirolo C, Testa N, Caniglia S, Morale MC, Impagnatiello F, Pluchino S, Marchetti B. 2013. Aging-induced Nrf2-ARE pathway disruption in the subventricular zone drives neurogenic impairment in parkinsonian mice via PI3K-Wnt/β-catenin dysregulation. J Neurosci. 33(4):1462–1485.
  • Leuner K, Hauptmann S, Abdel-Kader R, Scherping I, Keil U, Strosznajder JB, Eckert A, Müller WE. 2007. Mitochondrial dysfunction: the first domino in brain aging and Alzheimer's disease? Antioxid Redox Signal. 9(10):1659–1676.
  • Levenson CW, Tassabehji NM. 2007. Role and regulation of copper and zinc transport proteins in the central nervous system. In: Lajtha A, Reith MEA, editors. Handbook of neurochemistry and molecular neurobiology. Boston: Springer; p. 257–284.
  • Levi S, Rovida E-GS. 2009. The role of iron in mitochondrial function. Biochim Biophys Acta. 1790(7):629–636.
  • Lohmeier J. 2018. Calbindin-D28k and its role in apoptosis: inhibition of Caspase-3 activity and interaction with Pro-Caspase-3 investigated by in-situ FRET microscopy [Doctoral Thesis]. Munich: Ludwig Maximilian University. https://doi.org/10.5282/edoc.22430
  • Long X, Liao W, Jiang C, Liang D, Qiu B, Zhang L. 2012. Healthy aging: an automatic analysis of global and regional morphological alterations of human brain. Acad Radiol. 19(7):785–793.
  • Lores-Arnaiz S, Lombardi P, Karadayian AG, Orgambide F, Cicerchia D, Bustamante J. 2016. Brain cortex mitochondrial bioenergetics in synaptosomes and non-synaptic mitochondria during aging. Neurochem Res. 41(1-2):353–363.
  • Lu T, Pan Y, Kao S-Y, Li C, Kohane I, Chan J, Yankner BA. 2004. Gene regulation and DNA damage in the ageing human brain. Nature. 429(6994):883–891.
  • Lucchini RG, Guazzetti S, Zoni S, Benedetti C, Fedrighi C, Peli M, Donna F, Bontempi E, Borgese L, Micheletti S, et al. 2014. Neurofunctional dopaminergic impairment in elderly after lifetime exposure to manganese. Neurotoxicology. 45:309–317.
  • Lucchini RG, Smith DR, Tjalkens RB. 2013. CHAPTER 6 Manganese. Aging and Vulnerability to Environmental Chemicals: Age-related Disorders and Their Origins in Enviromental Exposures. The Royal Society of Chemistry. :151–181.
  • Madejczyk MS, Ballatori N. 2012. The iron transporter ferroportin can also function as a manganese exporter. Biochimica et Biophysica Acta (BBA)-Biomembranes. 1818(3):651–657.
  • Magalingam KB, Radhakrishnan A, Ping NS, Haleagrahara N. 2018. Current concepts of neurodegenerative mechanisms in Alzheimer’s disease. Biomed Res Int. 2018:3740461.
  • Manard M, Bahri MA, Salmon E, Collette F. 2016. Relationship between grey matter integrity and executive abilities in aging. Brain Res. 1642:562–580.
  • Marchi S, Patergnani S, Missiroli S, Morciano G, Rimessi A, Wieckowski MR, Giorgi C, Pinton PJCC. 2018. Mitochondrial and endoplasmic reticulum calcium homeostasis and cell death. Cell Calcium. 69:62–72.
  • Martinez-Finley EJ, Chakraborty S, Fretham SJ, Aschner MJM. 2012. Cellular transport and homeostasis of essential and nonessential metals. Metallomics. 4(7):593–605.
  • Martinez-Finley EJ, Gavin CE, Aschner M, Gunter TE. 2013. Manganese neurotoxicity and the role of reactive oxygen species. Free Radic Biol Med. 62:65–75.
  • Mattson MP, Arumugam TV. 2018. Hallmarks of brain aging: adaptive and pathological modification by metabolic states. Cell Metab. 27(6):1176–1199.
  • Mattson MP, Chan SL, Duan W. 2002. Modification of brain aging and neurodegenerative disorders by genes, diet, and behavior. Physiol Rev. 82(3):637–672.
  • Mattson MP, Magnus T. 2006. Ageing and neuronal vulnerability. Nat Rev Neurosci. 7(4):278–294.
  • McCord MC, Aizenman E. 2014. The role of intracellular zinc release in aging, oxidative stress, and Alzheimer’s disease. Front Aging Neurosci. 6:77.
  • Mercadante CJ, Prajapati M, Conboy HL, Dash ME, Herrera C, Pettiglio MA, Cintron-Rivera L, Salesky MA, Rao DB, Bartnikas TB. 2019. Manganese transporter Slc30a10 controls physiological manganese excretion and toxicity. J Clin Invest. 129(12):5442–5461.
  • Meunier D, Stamatakis EA, Tyler LK. 2014. Age-related functional reorganization, structural changes, and preserved cognition. Neurobiol Aging. 35(1):42–54.
  • Miah MR, Ijomone OM, Okoh COA, Ijomone OK, Akingbade GT, Ke T, Krum B, da Cunha Martins A, Akinyemi A, Aranoff N, et al. 2020. The effects of manganese overexposure on brain health. Neurochem Int. 135:104688.
  • Moloney AM, Griffin RJ, Timmons S, O'Connor R, Ravid R, O'Neill C. 2010. Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling. Neurobiol Aging. 31(2):224–243.
  • Montagne A, Barnes SR, Sweeney MD, Halliday MR, Sagare AP, Zhao Z, Toga AW, Jacobs RE, Liu CY, Amezcua L, et al. 2015. Blood-brain barrier breakdown in the aging human hippocampus. Neuron. 85(2):296–302.
  • Müller WE, Eckert A, Kurz C, Eckert GP, Leuner K. 2010. Mitochondrial dysfunction: common final pathway in brain aging and Alzheimer's disease-therapeutic aspects. Mol Neurobiol. 41(2-3):159–171.
  • Narciso L, Parlanti E, Racaniello M, Simonelli V, Cardinale A, Merlo D, Dogliotti E. 2016. The response to oxidative DNA damage in neurons: mechanisms and disease. Neural Plast. 2016:3619274.
  • Neth BJ, Craft S. 2017. Insulin resistance and Alzheimer's Disease: Bioenergetic Linkages. Front Aging Neurosci. 9:345.
  • Nixon RA. 2013. The role of autophagy in neurodegenerative disease. Nat Med. 19(8):983–997.
  • O’Neal SL, Zheng W. 2015. Manganese toxicity upon overexposure: a decade in review. Curr Environ Health Rep. 2(3):315–328.
  • Olanow CW. 2004. Manganese-induced parkinsonism and Parkinson's disease. Ann NY Acad Sci. 1012(1):209–223.
  • Olusola A, Obodozie O, Nssien M, Adaramoye A, Adesanoye O, Odama L, Emerole G. 2004. Concentrations of copper, iron, and zinc in the major organs of the wistar albino and wild black rats. BTER. 98(3):265–274.
  • Pandolfo M, Pastore A. 2009. The pathogenesis of Friedreich ataxia and the structure and function of frataxin. J Neurol. 256(S1):9–17.
  • Pandya JD, Royland JE, MacPhail RC, Sullivan PG, Kodavanti PRS. 2016. Age- and brain region-specific differences in mitochondrial bioenergetics in Brown Norway rats . Neurobiol Aging. 42:25–34.
  • Parmalee NL, Aschner M. 2016. Manganese and aging. Neurotoxicology. 56:262–268.
  • Phaniendra A, Jestadi DB, Periyasamy L. 2015. Free radicals: properties, sources, targets, and their implication in various diseases. Indian J Clin Biochem. 30(1):11–26.
  • Portbury SD, Adlard PA. 2017. Zinc signal in brain diseases. IJMS. 18(12):2506.
  • Proft J, Weiss N. 2015. Looking for answers to L-type calcium channels in the ageing brain (Commentary on Zanos et al.) Eur J Neurosci. 42(8):2496–2498.
  • Rainey RN, Ng S-y, Llamas J, van der Horst GT, Segil N. 2016. Mutations in cockayne syndrome-associated genes (Csa and Csb) predispose to cisplatin-induced hearing loss in mice. J Neurosci. 36(17):4758–4770.
  • Reddy PH. 2007. Mitochondrial dysfunction in aging and Alzheimer's disease: strategies to protect neurons. Antioxid Redox Signal. 9(10):1647–1658.
  • Regnell CE, Hildrestrand GA, Sejersted Y, Medin T, Moldestad O, Rolseth V, Krokeide SZ, Suganthan R, Luna L, Bjørås M, et al. 2012. Hippocampal adult neurogenesis is maintained by Neil3-dependent repair of oxidative DNA lesions in neural progenitor cells. Cell Rep. 2(3):503–510.
  • Rekik K, Francés B, Valet P, Dray C, Florian C. 2017. Cognitive deficit in hippocampal-dependent tasks in Werner syndrome mouse model. Behav Brain Res. 323:68–77.
  • Ricke KM, Paß T, Kimoloi S, Fährmann K, Jüngst C, Schauss A, Baris OR, Aradjanski M, Trifunovic A, Eriksson Faelker TM, et al. 2020. Mitochondrial dysfunction combined with high calcium load leads to impaired antioxidant defense underlying the selective loss of nigral dopaminergic neurons. J Neurosci. 40(9):1975–1986.
  • Rodier F, Coppé J-P, Patil CK, Hoeijmakers WA, Muñoz DP, Raza SR, Freund A, Campeau E, Davalos AR, Campisi J. 2009. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat Cell Biol. 11(8):973–979.
  • Rossi L, Arciello M, Capo C, Rotilio G. 2006. Copper imbalance and oxidative stress in neurodegeneration. Ital J Biochem. 55(3-4):212–221.
  • Roth J, Ponzoni S, Aschner M. 2013. Manganese homeostasis and transport. In: Banci L, editor. Metallomics and the Cell. Dordrecht: Springer; p. 169–201.
  • Ruszkiewicz JA, Pinkas A, Miah MR, Weitz RL, Lawes MJ, Akinyemi AJ, Ijomone OM. 2018. C. elegans as a Model in Developmental Neurotoxicology. Toxicol Appl Pharmacol. 354:126–135.
  • Salazar G, Craige B, Love R, Kalman D, Faundez V. 2005. Vglut1 and ZnT3 co-targeting mechanisms regulate vesicular zinc stores in PC12 cells. J Cell Sci. 118(Pt 9):1911–1921.
  • Santos RX, Correia SC, Zhu X, Smith MA, Moreira PI, Castellani RJ, Nunomura A, Perry G. 2013. Mitochondrial DNA oxidative damage and repair in aging and Alzheimer's disease. Antioxid Redox Signal. 18(18):2444–2457.
  • Scheibye-Knudsen M. 2015. Neurodegeneration in accelerated aging. Faculty of health and medical sciences. University of Copenhagen.
  • Schipper HM. 2012. Neurodegeneration with brain iron accumulation – clinical syndromes and neuroimaging. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 1822(3):350–360.
  • Seguin A, Bayot A, Dancis A, Rogowska-Wrzesinska A, Auchère F, Camadro J-M, Bulteau A-L, Lesuisse EJM. 2009. Overexpression of the yeast frataxin homolog (Yfh1): contrasting effects on iron-sulfur cluster assembly, heme synthesis and resistance to oxidative stress. Mitochondrion. 9(2):130–138.
  • Sen T, Jana S, Sreetama S, Chatterjee U, Chakrabarti S. 2007. Gene-specific oxidative lesions in aged rat brain detected by polymerase chain reaction inhibition assay. Free Radic Res. 41(3):288–294.
  • Sensi SL, Paoletti P, Bush AI, Sekler I. 2009. Zinc in the physiology and pathology of the CNS. Nat Rev Neurosci. 10(11):780–791.
  • Shi H, Deng H-X, Gius D, Schumacker PT, Surmeier DJ, Ma Y-C. 2017. Sirt3 protects dopaminergic neurons from mitochondrial oxidative stress. Hum Mol Genet. 26(10):1915–1926.
  • Simpson BN, Kim M, Chuang Y-F, Beason-Held L, Kitner-Triolo M, Kraut M, Lirette ST, Windham BG, Griswold ME, Legido-Quigley C, et al. 2016. Blood metabolite markers of cognitive performance and brain function in aging. J Cereb Blood Flow Metab. 36(7):1212–1223.
  • Singh I, Sagare AP, Coma M, Perlmutter D, Gelein R, Bell RD, Deane RJ, Zhong E, Parisi M, Ciszewski J, et al. 2013. Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearance. Proc Natl Acad Sci USA. 110(36):14771–14776.
  • Singh S. 2019. Zinc oxide nanoparticles impacts: Cytotoxicity, genotoxicity, developmental toxicity, and neurotoxicity. Toxicol Mech Methods. 29(4):300–311.
  • Soleimani SMA, Ekhtiari H, Cadet JL. 2016. Drug-induced neurotoxicity in addiction medicine: From prevention to harm reduction. Prog Brain Res. 223:19–41.
  • Soltow QA, Jones DP, Promislow DE. 2010. A network perspective on metabolism and aging. Integr Comp Biol. 50(5):844–854.
  • Stjepanović N. 2017. Utjecaj herbicida na molekularne biomarkere kod gujavice vrste Dandrobaena veneta (Rosa, 1886). Josip Juraj Strossmayer University of Osijek. Department of biology.
  • Stockburger C, Eckert S, Eckert GP, Friedland K, WEJJoAsD M. 2018. Mitochondrial function, dynamics, and permeability transition: a complex love triangle as a possible target for the treatment of brain aging and Alzheimer’s disease. J Alzheimers Dis. 64(s1):S455–S467.
  • Sun W, Winseck A, Vinsant S, Park O-h, Kim H, Oppenheim RW. 2004. Programmed cell death of adult-generated hippocampal neurons is mediated by the proapoptotic gene Bax. J Neurosci. 24(49):11205–11213.
  • Tanzi R, Moir R, Wagner S. 2004. Clearance of Alzheimer's Aβ peptide: the many roads to perdition. Neuron. 43(5):605–608.
  • Thambisetty M, Beason-Held LL, An Y, Kraut M, Metter J, Egan J, Ferrucci L, O'Brien R, Resnick SM. 2013. Impaired glucose tolerance in midlife and longitudinal changes in brain function during aging. Neurobiol Aging. 34(10):2271–2276.
  • Tian L, Lin B, Wu L, Li K, Liu H, Yan J, Liu X, Xi Z. 2015. Neurotoxicity induced by zinc oxide nanoparticles: age-related differences and interaction. Sci Rep. 5:16117.
  • Tiwari SK, Agarwal S, Seth B, Yadav A, Nair S, Bhatnagar P, Karmakar M, Kumari M, Chauhan LKS, Patel DK, et al. 2014. Curcumin-loaded nanoparticles potently induce adult neurogenesis and reverse cognitive deficits in Alzheimer's disease model via canonical Wnt/β-catenin pathway . ACS Nano. 8(1):76–103.
  • Toescu EC, Verkhratsky A, Landfield PW. 2004. Ca2+ regulation and gene expression in normal brain aging. Trends Neurosci. 27(10):614–620.
  • Torregrossa AC, Aranke M, Bryan NS. 2011. Nitric oxide and geriatrics: Implications in diagnostics and treatment of the elderly. J Geriatr Cardiol. 8(4):230–242.
  • Turan B, Billur D, Olgar Y. 2019. Zinc signaling in aging heart function. In: Zinc signaling. Springer; p. 139–164.
  • Tuschl K, Meyer E, Valdivia LE, Zhao N, Dadswell C, Abdul-Sada A, Hung CY, Simpson MA, Chong WK, Jacques TS, et al. 2016. Mutations in SLC39A14 disrupt manganese homeostasis and cause childhood-onset parkinsonism-dystonia. Nat Commun. 7:11601.
  • Uryash A, Flores V, Adams JA, Allen PD, Lopez JR, Lopez JRJFiAN. 2020. Memory and learning deficits are associated with Ca2+ dyshomeostasis in normal aging. Front Aging Neurosci. 12:224.
  • Vigani G, Hanikenne M. 2018. Metal homeostasis in plant mitochondria, Chapter 5. In: Logan DC, editor. Plant Mitochondria; Annual Plant Reviews. New Jersey: John Wiley & Sons, Ltd; p. 111–142.
  • Waggoner D, Drisaldi B, Bartnikas T, Casareno RL, Prohaska JR, Gitlin JD, Harris DA. 2000. Brain copper content and cuproenzyme activity do not vary with prion protein expression level. J Biol Chem. 275(11):7455–7458.
  • Walker T, Michaelides C, Ekonomou A, Geraki K, Parkes HG, Suessmilch M, Herlihy AH, Crum WR, So P-W. 2016. Dissociation between iron accumulation and ferritin upregulation in the aged substantia nigra: attenuation by dietary restriction. Aging (Albany NY). 8(10):2488–2508.
  • Wang H, Wang M, Wang B, Li M, Chen H, Yu X, Zhao Y, Feng W, Chai Z. 2012. The distribution profile and oxidation states of biometals in APP transgenic mouse brain: dyshomeostasis with age and as a function of the development of Alzheimer's disease. Metallomics. 4(3):289–296.
  • Wang L-M, Becker JS, Wu Q, Oliveira MF, Bozza FA, Schwager AL, Hoffman JM, Morton KA. 2010. Bioimaging of copper alterations in the aging mouse brain by autoradiography, laser ablation inductively coupled plasma mass spectrometry and immunohistochemistry. Metallomics. 2(5):348–353.
  • Weidenheim KM, Dickson DW, Rapin I. 2009. Neuropathology of Cockayne syndrome: Evidence for impaired development, premature aging, and neurodegeneration. Mech Ageing Dev. 130(9):619–636.
  • Wong KY, Roy J, Fung ML, Heng BC, Zhang C, Lim LW. 2020. Relationships between mitochondrial dysfunction and neurotransmission failure in Alzheimer’s disease. Aging and Disease. 11(15):1291–1316.
  • Woźniak A, Drewa G, Woźniak B, Schachtschabel D. 2004. Activity of antioxidant enzymes and concentration of lipid peroxidation products in selected tissues of mice of different ages, both healthy and melanoma-bearing. Z Gerontol Geriatr. 37(3):184–189.
  • Xiaoli F, Junrong W, Xuan L, Yanli Z, Limin W, Jia L, Longquan SJN. 2017. Prenatal exposure to nanosized zinc oxide in rats: neurotoxicity and postnatal impaired learning and memory ability. Nanomedicine (Lond). 12(7):777–795.
  • Xu J, Marzetti E, Seo AY, Kim J-S, Prolla TA, Leeuwenburgh C. 2010. The emerging role of iron dyshomeostasis in the mitochondrial decay of aging. Mech Ageing Dev. 131(7-8):487–493.
  • Xu SC, He MD, Zhong M, Zhang YW, Wang Y, Yang L, Yang J, Yu ZP, Zhou Z. 2010. Melatonin protects against Nickel-induced neurotoxicity in vitro by reducing oxidative stress and maintaining mitochondrial function . J Pineal Res. 49(1):86–94.
  • Yaffe K, Fiocco AJ, Lindquist K, Vittinghoff E, Simonsick EM, Newman AB, Satterfield S, Rosano C, Rubin SM, Ayonayon HN. 2009. Predictors of maintaining cognitive function in older adults. The Health ABC Study. 72(23):2029–2035.
  • Yang J-L, Tadokoro T, Keijzers G, Mattson MP, Bohr VA. 2010. Neurons efficiently repair glutamate-induced oxidative DNA damage by a process involving CREB-mediated up-regulation of apurinic endonuclease 1. J Biol Chem. 285(36):28191–28199.
  • Yarchoan M, Toledo JB, Lee EB, Arvanitakis Z, Kazi H, Han L-Y, Louneva N, Lee VM-Y, Kim SF, Trojanowski JQ, et al. 2014. Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer's disease and tauopathies. Acta Neuropathol. 128(5):679–689.
  • Zarkovic K, Jakovcevic A, Zarkovic N. 2017. Contribution of the HNE-immunohistochemistry to modern pathological concepts of major human diseases. Free Radic Biol Med. 111:110–126.
  • Zhang H, Davies KJ, Forman HJ. 2015. Oxidative stress response and Nrf2 signaling in aging. Free Radic Biol Med. 88(Pt B):314–336.
  • Zhang S, Eitan E, Mattson MP. 2017. Early involvement of lysosome dysfunction in the degeneration of cerebral cortical neurons caused by the lipid peroxidation product 4-hydroxynonenal. J Neurochem. 140(6):941–954.
  • Zheng W, Monnot AD. 2012. Regulation of brain iron and copper homeostasis by brain barrier systems: implication in neurodegenerative diseases. Pharmacol Ther. 133(2):177–188.
  • Zorova LD, Popkov VA, Plotnikov EY, Silachev DN, Pevzner IB, Jankauskas SS, Babenko VA, Zorov SD, Balakireva AV, Juhaszova M, et al. 2018. Mitochondrial membrane potential. Anal Biochem. 552:50–59.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.